Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11741240 | 1.00 | SMN1; SMN2 (0.49) | SMN1; SMN2KMT2AMEN1POLBGAA | |
| SCHEMBL12611248 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2KMT2AMEN1POLBPRCP | |
| SCHEMBL11735520 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2KMT2AMEN1POLBPRCP | |
| SCHEMBL9548201 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2KMT2AMEN1POLBGAA | |
| SCHEMBL9548205 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2KMT2AMEN1POLBGAA | |
| SCHEMBL11738552 | 0.83 | PRCP (0.53) | SMN1; SMN2PRCP | |
| SCHEMBL13300990 | 0.83 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AMEN1POLBGAA | |
| SCHEMBL5581114 | 0.83 | SMN1; SMN2 (0.47) | SMN1; SMN2KMT2AMEN1POLBGAA | |
| SCHEMBL11746495 | 0.82 | PRCP (0.59) | SMN1; SMN2PRCPCNR1DAGLA | |
| SCHEMBL9548185 | 0.82 | SMN1; SMN2 (0.49) | SMN1; SMN2KMT2AMEN1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304423-B2 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICAL INCORPORATED (US) | 2012-11-06 | — | — | US | disclosed |
| US-8293757-B2 | 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors | IRM LLC (BM) | 2012-10-23 | — | — | US | disclosed |
| US-8288540-B2 | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors | IRM LLC (BM) | 2012-10-16 | — | — | US | disclosed |
| US-8003660-B2 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110053952-A1 | 2-HETEROARYLAMINO-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | IRM LLC (BM) | 2011-03-03 | — | — | US | disclosed |
| US-20070285603-A1 | Transparent Film And Optical Compensatory Film, Polarizing Plate And Liquid-Crystal Display Device Employing It | FUJI PHOTO FILM CO., LTD. (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070213315-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2007-09-13 | — | — | US | disclosed |
| US-20070059458-A1 | Cellulose acylate film, optically compensatory film, polarizing plate and liquid crystal display | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213315-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | SMN1; SMN2 3349/4885KMT2A 2362/4885MEN1 2672/4885 |
| US-20110053952-A1 | 2-HETEROARYLAMINO-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | FYN, LCK, ERBB2 | SMN1; SMN2 2345/4885KMT2A 1233/4885MEN1 4779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.